Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Tandem Diabetes Care (TNDM) over the last 12 years, with Q3 2025 value amounting to $54.1 million.

  • Tandem Diabetes Care's Change in Acquisitions & Divestments fell 821.3% to $54.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $268.0 million, marking a year-over-year decrease of 2751.7%. This contributed to the annual value of $306.5 million for FY2024, which is 4389.35% down from last year.
  • Latest data reveals that Tandem Diabetes Care reported Change in Acquisitions & Divestments of $54.1 million as of Q3 2025, which was down 821.3% from $81.4 million recorded in Q2 2025.
  • In the past 5 years, Tandem Diabetes Care's Change in Acquisitions & Divestments ranged from a high of $168.4 million in Q2 2021 and a low of $54.1 million during Q3 2025
  • Its 5-year average for Change in Acquisitions & Divestments is $115.4 million, with a median of $118.6 million in 2021.
  • Per our database at Business Quant, Tandem Diabetes Care's Change in Acquisitions & Divestments skyrocketed by 60610.9% in 2021 and then plummeted by 4871.56% in 2024.
  • Quarter analysis of 5 years shows Tandem Diabetes Care's Change in Acquisitions & Divestments stood at $142.8 million in 2021, then grew by 2.68% to $146.6 million in 2022, then fell by 10.81% to $130.7 million in 2023, then plummeted by 48.42% to $67.4 million in 2024, then fell by 19.72% to $54.1 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $54.1 million for Q3 2025, versus $81.4 million for Q2 2025 and $65.1 million for Q1 2025.